TrialHuman vaccines & immunotherapeutics2019

Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials.

Ngoc Huu Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.